Xcout IntelSign inSubscribe

Sonoma Biotherapeutics, Inc.

BiotechnologySouth San Francisco, CA, United States

Sonoma Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing engineered regulatory T cell therapies for autoimmune and inflammatory diseases. The company is headquartered in South San Francisco, California.

Subscribe to see Sonoma Biotherapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Sonoma Biotherapeutics, Inc. at a glance

Sonoma Biotherapeutics, Inc. is a biotechnology company headquartered in South San Francisco, United States. It has raised at least $335M across the 3 funding rounds on record. Its most recent funding round raised $265M in July 2021. Xcout tracks 5 named people at Sonoma Biotherapeutics, Inc., including Stephen Dilly (President and Chief Executive Officer).

As of 17 November 2026. Source: Xcout Intel.

Industry
Biotechnology
Headquarters
South San Francisco, CA, United States
Raised, rounds on record
$335M

Sonoma Biotherapeutics, Inc. leadership

  • Stephen DillyPresident and Chief Executive Officer
  • Lisa Taylor AshCOO
  • Jessica StittCFO & CBO
  • Joshua BeilkeCSO, Head of Technical Operations
  • Matteo LevisettiCMO

Sonoma Biotherapeutics, Inc. funding rounds

At least $335M raised across the 3 rounds on record. Every round on record:

DateRoundAmountInvestors
SEC Form D filing$265M—
—$30M14 named
—$40M13 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Who funded each Sonoma Biotherapeutics, Inc. round

A funding-flow diagram of the 14 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.

Sign in to see it, or subscribe for the full funding history →

Investors

Sonoma Biotherapeutics, Inc. competitors

A few of Sonoma Biotherapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →

Get Sonoma Biotherapeutics, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Sonoma Biotherapeutics, Inc.? Suggest a correction · Work at Sonoma Biotherapeutics, Inc.? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Sonoma Biotherapeutics, Inc. on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Sonoma Biotherapeutics, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Sonoma Biotherapeutics, Inc. in Xcout Intel

  • 5 named people with titles, LinkedIn and board committees
  • 3 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →